Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1995 1
1997 3
1999 5
2003 2
2004 2
2006 3
2007 4
2008 4
2009 7
2010 8
2011 10
2012 7
2013 2
2014 5
2015 3
2016 1
2018 2
2019 4
2020 2
2021 7
2022 12
2023 5
2024 2
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, López-Sendón J, Alexander KP, Lopes RD, Shaw LJ, Berger JS, Newman JD, Sidhu MS, Goodman SG, Ruzyllo W, Gosselin G, Maggioni AP, White HD, Bhargava B, Min JK, Mancini GBJ, Berman DS, Picard MH, Kwong RY, Ali ZA, Mark DB, Spertus JA, Krishnan MN, Elghamaz A, Moorthy N, Hueb WA, Demkow M, Mavromatis K, Bockeria O, Peteiro J, Miller TD, Szwed H, Doerr R, Keltai M, Selvanayagam JB, Steg PG, Held C, Kohsaka S, Mavromichalis S, Kirby R, Jeffries NO, Harrell FE Jr, Rockhold FW, Broderick S, Ferguson TB Jr, Williams DO, Harrington RA, Stone GW, Rosenberg Y; ISCHEMIA Research Group. Maron DJ, et al. N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30. N Engl J Med. 2020. PMID: 32227755 Free PMC article. Clinical Trial.
Chromothripsis, DNA repair and checkpoints defects.
Simovic M, Ernst A. Simovic M, et al. Semin Cell Dev Biol. 2022 Mar;123:110-114. doi: 10.1016/j.semcdb.2021.02.001. Epub 2021 Feb 13. Semin Cell Dev Biol. 2022. PMID: 33589336 Free article. Review.
Endogenous T cells prevent tumor immune escape following adoptive T cell therapy.
Walsh SR, Simovic B, Chen L, Bastin D, Nguyen A, Stephenson K, Mandur TS, Bramson JL, Lichty BD, Wan Y. Walsh SR, et al. J Clin Invest. 2019 Dec 2;129(12):5400-5410. doi: 10.1172/JCI126199. J Clin Invest. 2019. PMID: 31682239 Free PMC article.
While the outcome of adoptive T cell therapy (ACT) is typically correlated with the functionality of the inoculated T cells, the role of the endogenous T cells is unknown. ...Moreover, while transferred T cells disappeared shortly after tumor regressio …
While the outcome of adoptive T cell therapy (ACT) is typically correlated with the functionality of the inoculated T cells, t …
Semaglutide decelerates the growth and progression of breast cancer by enhancing the acquired antitumor immunity.
Stanisavljevic I, Pavlovic S, Simovic Markovic B, Jurisevic M, Krajnovic T, Mijatovic S, Spasojevic M, Mitrovic S, Corovic I, Jovanovic I. Stanisavljevic I, et al. Biomed Pharmacother. 2024 Dec;181:117668. doi: 10.1016/j.biopha.2024.117668. Epub 2024 Nov 12. Biomed Pharmacother. 2024. PMID: 39536536 Free article.
However, semaglutide increased the accumulation and maturation of CD11c(+) dendritic cell, while decreasing the percentage of FoxP3(+) regulatory T cells in the spleen and primary tumor. In addition, semaglutide increased tumor infiltration and promoted the antitumor pheno …
However, semaglutide increased the accumulation and maturation of CD11c(+) dendritic cell, while decreasing the percentage of FoxP3(+) regul …
EHRA: a 20-year journey of success.
Duncker D, Leclercq C, Pürerfellner H, Waldmann V, Simovic S, Li A, Bhardwaj P, Palayan S, Meyen V, Tapp L, Merino JL. Duncker D, et al. Europace. 2023 Apr 15;25(4):1201-1207. doi: 10.1093/europace/euad070. Europace. 2023. PMID: 37061782 Free PMC article. No abstract available.
SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms.
Nikolic M, Zivkovic V, Jovic JJ, Sretenovic J, Davidovic G, Simovic S, Djokovic D, Muric N, Bolevich S, Jakovljevic V. Nikolic M, et al. Heart Fail Rev. 2022 May;27(3):935-949. doi: 10.1007/s10741-021-10079-9. Epub 2021 Feb 3. Heart Fail Rev. 2022. PMID: 33534040 Review.
IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice.
Edgerton C, Crispín JC, Moratz CM, Bettelli E, Oukka M, Simovic M, Zacharia A, Egan R, Chen J, Dalle Lucca JJ, Juang YT, Tsokos GC. Edgerton C, et al. Clin Immunol. 2009 Mar;130(3):313-21. doi: 10.1016/j.clim.2008.09.019. Epub 2008 Dec 5. Clin Immunol. 2009. PMID: 19058762 Free PMC article.
Depletion of T cells limited I/R damage in B6.MRL/lpr mice, whereas repletion of B6.MRL/lpr lymph node-derived T cells into the I/R-resistant Rag-1(-/-) mouse reconstituted tissue injury. ...Our data assign T cells a major role in intestinal I/R damage by vir …
Depletion of T cells limited I/R damage in B6.MRL/lpr mice, whereas repletion of B6.MRL/lpr lymph node-derived T cells into th …
OPCML: A Promising Biomarker and Therapeutic Avenue.
Simovic I, Castaño-Rodríguez N, Kaakoush NO. Simovic I, et al. Trends Cancer. 2019 Aug;5(8):463-466. doi: 10.1016/j.trecan.2019.06.002. Epub 2019 Jun 28. Trends Cancer. 2019. PMID: 31421903
92 results